Enlarged adenoids
Conditions
Interventions
Control group A1:Montelukast Sodium Tablets + Qingfei Huatan Tongqiao Formula Placebo
Treatment Group B1:Montelukast sodium placebo + Qingfei Huatan Tongqiao decoction
Control group A2:Montelukast Sodium Tablets + Yunpi Huatan Tongqiao Formula Placebo
Treatment Group B2:Montelukast sodium placebo + Yunpihua Tan Tongqiao formula
Sponsors
Shanghai University of Traditional Chinese Medicine Affiliated Longhua Hospital
Eligibility
Sex/Gender
All
Age
3 Years to 14 Years
Inclusion criteria
Inclusion criteria: (1) Meets the diagnostic criteria for adenoid hypertrophy; (2) Age 3 to 14 years, gender; (3) The subject's parent/legal guardian has signed the informed consent form and is able to cooperate.
Exclusion criteria
Exclusion criteria: (1) Those with severe deviated nasal septum, due to obesity, nasal polyps, upper airway neuromuscular tension, or diseases of the throat and trachea, resulting in breathing difficulties; (2) Those with severe liver or kidney diseases, cardiovascular diseases, endocrine diseases, hematological diseases, or neurological diseases; (3) Those who are known to be allergic to any of the drugs in this prescription; (4) Those currently participating in other clinical drug trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The grading and quantification of adenoid hypertrophy.;Traditional Chinese Medicine Syndrome Criteria; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sleep Breathing Monitoring;Quality of Life Evaluation:Obstructive Sleep Apnea Specific Quality of Life Survey, 18 items survey; | — |
Countries
China
Contacts
Public ContactXiao Zhen
Shanghai University of Traditional Chinese Medicine Affiliated Longhua Hospital
Outcome results
None listed